Cosmo Pharmaceuticals NV 2022 Annual Report with Sustainability Disclosures
Company: Cosmo Pharmaceuticals NV
Sector: Manufacturing
Country: Ireland
Year: 2022
Type: Annual Report with Sustainability Disclosures
Pages: 159
The report describes 2022 as Cosmo's best year ever, with revenue rising to €102.1 million and new products including Winlevi and GI Genius contributing substantial revenues. It documents Board-level ESG oversight through an Environmental, Social & Governance Committee, alongside an environmental management system and sustainable-practice commitments. The report discloses total energy consumption of 28,011 MWh, water consumption of 0.088 millions of m3 per annum and a Group workforce of 295 people. It also reports that 37% of the workforce are women and describes a commitment to human rights and environmental responsibility.
Indicators available in this report: